Thrombotic disorders.
The causes and consequences of thrombosis are of interest and concern to a wide range of clinicians and scientists. Accordingly, the Royal College of Physicians joined with the Haemostasis and Thrombosis Task Force of the British Society for Haematology to hold a conference on thrombotic disorders in October 1995. The aim of the conference was to highlight and discuss recent advances in identifying patients at risk of thrombosis and ways of inhibiting the coagulation cascade and platelet function.
Collins
P
P
Great Ormond Street Hospital.
Kelsey
H
H
D017152:Antibodies, Antiphospholipid / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use; D015415:Biomarkers; D001779:Blood Coagulation Factors / Q000502:physiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*
D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D015415:Biomarkers; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors